AJCP / Meeting AbstrActs findings, microscopic examination and immunohistochemistry, a diagnosis of true neuronal heterotopia of the middle ear was rendered.
Middle ear adenoma (MEA) is an uncommon (<2% of ear tumors) benign glandular neoplasm of the middle ear. MEA occurs equally in both genders and over a wide age range, but it is most common in the third to fifth decade of life. Any portion of the middle ear may be affected, including the Eustachian tube, mastoid air spaces, ossicles, and chorda tympani nerve. The most common symptom is unilateral conductive hearing loss, but fullness, tinnitus, and dizziness may also occur. In the majority of cases, otoscopic examination identifies an intact tympanic membrane with a tumor that is confined to the middle ear space with possible extension to the mastoid. Here we report a case of a 15-year-old boy with a two-year history of hearing loss and fullness of the left ear. Physical examination of the tympanic membrane reveals posterior superior retraction with some debris that was difficult to remove. Excision of the lesion was performed. Microscopic examination revealed a dual cell population: inner luminal cells with eosinophilic cytoplasm and outer cuboidal/ columnar cells with indistinct cytoplasm. The nuclei are round to oval, eccentrically placed "plasmacytoid," with minimal pleomorphism and dispersed chromatin pattern. No mitotic figures were noted. Immunohistochemical stains showed strong AE1/AE3, CAM5.2. Based on the morphology and immunohistochemistry, a diagnosis of middle ear adenoma was rendered. Objectives: Renal cell carcinoma (RCC) accounts for approximately 3% of all adult malignancies. Common metastatic sites include lung, bone, and liver. However, head and neck region metastases from a renal cell carcinoma are an uncommon clinical manifestation. We performed a retrospective review to assess the incidence of metastatic renal cell carcinoma in the head and neck region and sites of involvement.
Methods: Our surgical pathology files from 1990 to 2015 were searched to identify cases of metastatic RCC in the head and neck region. Pertinent clinicopathologic data were reviewed. Results: A total of 565 RCC cases were identified. Fifteen of 565 (2.6%) had metastatic RCC to the head and neck region. Of these 15 patients, there were 10 men and five women. The median age at diagnosis was 63 years, ranging from 37 to 76 years. The most common sites of metastases were thyroid and scalp with sinuses, skull, lymph node, and maxilla involved in decreasing order of frequency. Two of 15 (13.3%) cases presented with distant (head and neck) metastases at the time of diagnosis. The median time of diagnosis of metastasis for 12/15(80%) cases was 73 months. Twelve of 15 cases had predominantly "clear cell" morphology in the metastatic lesion. Conclusion: Our study illustrates a variety of extracranial metastatic sites in the head and neck affected by RCC. Since the majority of metastatic tumors had clear cell morphology, it may be difficult to differentiate a primary clear cell tumor of the salivary glands or thyroid gland vs a metastatic RCC, especially in patients with an occult primary RCC. Patients with RCC are well known to have late metastases during their course of disease. Mean time of metastasis in our study was 73 months.
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Cholangiocarcinoma of the Young: Clinicopathologic Features
Cristiane Ida, Taofic Mounajjed, MD; Mayo Clinic, Rochester, MN Objectives: This study aims to evaluate clinicopathologic features of cholangiocarcinomas arising in young individuals. Methods: We searched our pathology database for cholangiocarcinomas arising in individuals younger than 30 years old. Tumor pathologic features and clinical data were collected. Immunohistochemical stains for CK7, CK20, CK19, p53, NCAM, N-cadherin, S100P, MLH1, MSH2, PMS2, and MSH6 were obtained on patient samples and a control group of 22 cholangiocarcinomas arising in older individuals (>50 years). Results: Twenty patients ranged in age between 11 and 29 years (mean 24.7). Most (55%) were female patients. Tumors were perihilar in 10 (50%), distal in one (5%), and intrahepatic in nine (45%) patients. Seven patients (35%) had primary sclerosing cholangitis. The tumors were moderately differentiated (n = 8, 44%), poorly differentiated (n = 7, 39%), and undifferentiated (n = 3, 17%) adenocarcinomas; the remaining two cases included an adenocarcinoma diagnosed by cytology and a neuroendocrine carcinoma. The overall pathologic stage at presentation or resection was I (16%), II (26%), III (16%), and IV (42%).
